Chien Jennifer's Insider Trades & SAST Disclosures
Chien Jennifer's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 9,169 Common Stock done at an average price of $38.2 . Disclosure was reported to the exchange on March 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Chien Jennifer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 38.22 per share. | 20 Mar 2024 | 9,169 | 15,918 (0%) | 0% | 38.2 | 350,439 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 39.33 per share. | 20 Mar 2024 | 9,066 | 6,852 (0%) | 0% | 39.3 | 356,566 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 39.22 per share. | 19 Mar 2024 | 15,515 | 25,087 (0%) | 0% | 39.2 | 608,498 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 67,000 | 67,000 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Chien Jennifer | EVP, Head of North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 33,750 | 40,602 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Chien Jennifer | EVP, Head of North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 22,000 | 22,000 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 3,438 | 6,874 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Chien Jennifer | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 3,438 | 6,459 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,031 | 8,490 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Chien Jennifer | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,031 | 2,031 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 51.38 per share. | 09 Feb 2024 | 1,023 | 7,467 (0%) | 0% | 51.4 | 52,562 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 49.83 per share. | 09 Feb 2024 | 615 | 6,852 (0%) | 0% | 49.8 | 30,645 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 4,513 | 13,537 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Chien Jennifer | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 4,513 | 4,513 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Chien Jennifer | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 45.06 per share. | 01 Feb 2024 | 1,492 | 3,021 (0%) | 0% | 45.1 | 67,230 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 24.18 per share. | 07 Aug 2023 | 11,223 | 3,294 (0%) | 0% | 24.2 | 271,347 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 8,591 | 73,909 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 07 Aug 2023 | 8,591 | 14,517 (0%) | 0% | 6.8 | 58,419 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 24.66 per share. | 07 Aug 2023 | 1,718 | 3,294 (0%) | 0% | 24.7 | 42,366 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 07 Aug 2023 | 1,718 | 5,012 (0%) | 0% | 6.8 | 11,682 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 1,718 | 72,191 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,031 | 4,062 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,031 | 5,575 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 26.87 per share. | 11 Feb 2023 | 635 | 4,940 (0%) | 0% | 26.9 | 17,062 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 09 Feb 2023 | 1,204 | 3,544 (0%) | 0% | 27.5 | 33,122 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 46,900 | 46,900 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 18,050 | 18,050 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,032 | 2,032 (0%) | 0% | - | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,032 | 6,093 | - | - | Restricted Stock Units | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Sale of securities on an exchange or to another person at price $ 6.10 per share. | 11 Feb 2022 | 722 | 1,310 (0%) | 0% | 6.1 | 4,404 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 48,750 | 48,750 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Jennifer Chien | EVP, Head of North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 8,125 | 8,125 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges